Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 346

1.

Concise review: Induced pluripotent stem cell-derived mesenchymal stem cells: progress toward safe clinical products.

Jung Y, Bauer G, Nolta JA.

Stem Cells. 2012 Jan;30(1):42-7. doi: 10.1002/stem.727. Review.

2.

Does the adult stroma contain stem cells?

Schäfer R.

Adv Biochem Eng Biotechnol. 2013;129:177-89. doi: 10.1007/10_2012_160. Review.

PMID:
23117643
3.

Small molecule mesengenic induction of human induced pluripotent stem cells to generate mesenchymal stem/stromal cells.

Chen YS, Pelekanos RA, Ellis RL, Horne R, Wolvetang EJ, Fisk NM.

Stem Cells Transl Med. 2012 Feb;1(2):83-95. doi: 10.5966/sctm.2011-0022. Epub 2012 Feb 7.

4.

Induction of pluripotency in human umbilical cord mesenchymal stem cells in feeder layer-free condition.

Daneshvar N, Rasedee A, Shamsabadi FT, Moeini H, Mehrboud P, Rahman HS, Boroojerdi MH, Vellasamy S.

Tissue Cell. 2015 Dec;47(6):575-82. doi: 10.1016/j.tice.2015.04.005. Epub 2015 Apr 24.

PMID:
26471847
5.

Roadblocks en route to the clinical application of induced pluripotent stem cells.

Lowry WE, Quan WL.

J Cell Sci. 2010 Mar 1;123(Pt 5):643-51. doi: 10.1242/jcs.054304.

6.

Generation of functional mesenchymal stem cells from different induced pluripotent stem cell lines.

Hynes K, Menicanin D, Mrozik K, Gronthos S, Bartold PM.

Stem Cells Dev. 2014 May 15;23(10):1084-96. doi: 10.1089/scd.2013.0111. Epub 2014 Feb 7.

7.

Concise review: Deciphering the mechanism behind induced pluripotent stem cell generation.

Lin SL.

Stem Cells. 2011 Nov;29(11):1645-9. doi: 10.1002/stem.744. Review.

8.

Human stem cell research and regenerative medicine--present and future.

Volarevic V, Ljujic B, Stojkovic P, Lukic A, Arsenijevic N, Stojkovic M.

Br Med Bull. 2011;99:155-68. doi: 10.1093/bmb/ldr027. Epub 2011 Jun 13. Review.

PMID:
21669982
9.

Cell reprogramming: expectations and challenges for chemistry in stem cell biology and regenerative medicine.

Anastasia L, Pelissero G, Venerando B, Tettamanti G.

Cell Death Differ. 2010 Aug;17(8):1230-7. doi: 10.1038/cdd.2010.14. Epub 2010 Feb 19. Review.

10.

Generation of human β-thalassemia induced pluripotent cell lines by reprogramming of bone marrow-derived mesenchymal stromal cells using modified mRNA.

Varela I, Karagiannidou A, Oikonomakis V, Tzetis M, Tzanoudaki M, Siapati EK, Vassilopoulos G, Graphakos S, Kanavakis E, Goussetis E.

Cell Reprogram. 2014 Dec;16(6):447-55. doi: 10.1089/cell.2014.0050. Epub 2014 Oct 29.

PMID:
25354259
11.

Different developmental potential of pluripotent stem cells generated by different reprogramming strategies.

Jiang J, Ding G, Lin J, Zhang M, Shi L, Lv W, Yang H, Xiao H, Pei G, Li Y, Wu J, Li J.

J Mol Cell Biol. 2011 Jun;3(3):197-9. doi: 10.1093/jmcb/mjr012. No abstract available.

PMID:
21624975
12.

Malignant germ cell-like tumors, expressing Ki-1 antigen (CD30), are revealed during in vivo differentiation of partially reprogrammed human-induced pluripotent stem cells.

Griscelli F, Féraud O, Oudrhiri N, Gobbo E, Casal I, Chomel JC, Biéche I, Duvillard P, Opolon P, Turhan AG, Bennaceur-Griscelli A.

Am J Pathol. 2012 May;180(5):2084-96. doi: 10.1016/j.ajpath.2012.01.011. Epub 2012 Mar 13.

PMID:
22425713
13.

Concise review: non-cell autonomous reprogramming: a nucleic acid-free approach to induction of pluripotency.

Parameswaran S, Balasubramanian S, Rao MS, Ahmad I.

Stem Cells. 2011 Jul;29(7):1013-20. doi: 10.1002/stem.655. Review.

14.

Progress and promise towards safe induced pluripotent stem cells for therapy.

Seifinejad A, Tabebordbar M, Baharvand H, Boyer LA, Salekdeh GH.

Stem Cell Rev. 2010 Jun;6(2):297-306. doi: 10.1007/s12015-010-9121-x. Review.

PMID:
20180049
15.

Feeder-free derivation of induced pluripotent stem cells from human immature dental pulp stem cells.

Beltrão-Braga PC, Pignatari GC, Maiorka PC, Oliveira NA, Lizier NF, Wenceslau CV, Miglino MA, Muotri AR, Kerkis I.

Cell Transplant. 2011;20(11-12):1707-19. doi: 10.3727/096368911X566235. Epub 2011 Apr 1.

PMID:
21457612
16.

Human pluripotent stem cells differentiated in fully defined medium generate hematopoietic CD34- and CD34+ progenitors with distinct characteristics.

Chicha L, Feki A, Boni A, Irion O, Hovatta O, Jaconi M.

PLoS One. 2011 Feb 25;6(2):e14733. doi: 10.1371/journal.pone.0014733.

17.

Application of induced pluripotent stem cells to hematologic disease.

Kim PG, Daley GQ.

Cytotherapy. 2009;11(8):980-9. doi: 10.3109/14653240903348319. Review.

PMID:
19929461
18.

Cell therapy using induced pluripotent stem cells or somatic stem cells: this is the question.

Somoza RA, Rubio FJ.

Curr Stem Cell Res Ther. 2012 May;7(3):191-6. Review.

PMID:
22329581
19.

Progress made in the reprogramming field: new factors, new strategies and a new outlook.

Hussein SM, Nagy AA.

Curr Opin Genet Dev. 2012 Oct;22(5):435-43. doi: 10.1016/j.gde.2012.08.007. Epub 2012 Sep 5. Review.

PMID:
22959308
20.

Mesenchymal stem cells from iPS cells facilitate periodontal regeneration.

Hynes K, Menicanin D, Han J, Marino V, Mrozik K, Gronthos S, Bartold PM.

J Dent Res. 2013 Sep;92(9):833-9. doi: 10.1177/0022034513498258. Epub 2013 Jul 24.

PMID:
23884555

Supplemental Content

Support Center